Have a personal or library account? Click to login
Retroperitoneal pararenal dedifferentiated liposarcoma with epithelioid/neuroendocrine features, somatostatin-positive. Cover

Retroperitoneal pararenal dedifferentiated liposarcoma with epithelioid/neuroendocrine features, somatostatin-positive.

Forum of Clinical Oncology
Volume 13 (2022): Issue 1 (December 2022)
By: Gabriele Gaggero,  Paola Bet,  Davide Taietti,  Marta Ingaliso and  Bruno Spina  
Open Access
|Aug 2023

Authors

Gabriele Gaggero

gabriele.gaggero@hsanmartino.it

IRCCS Ospedale Policlinico San Martino, UO Anatomia patologica ospedaliera, Genova, Italy

Paola Bet

IRCCS Ospedale Policlinico San Martino, UO Anatomia patologica ospedaliera, Genova, Italy

Davide Taietti

Pathology Unit, ASST del Garda, Desenzano del Garda (Brescia), Brescia, Italy

Marta Ingaliso

Università di Genova, Scuola di Scienze Mediche e Farmaceutiche, Department of Integrated Surgical and Diagnostic Sciences (DISC), Division of Anatomic Pathology, Genova, Italy

Bruno Spina

IRCCS Ospedale Policlinico San Martino, UO Anatomia patologica ospedaliera, Genova, Italy
DOI: https://doi.org/10.2478/fco-2022-0007 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 63 - 65
Submitted on: Nov 13, 2022
|
Accepted on: Jan 4, 2023
|
Published on: Aug 3, 2023
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
liposarcoma,
dedifferentiated,
epithelioid,
neuroendocrine,
somatostatin,
MDM2
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2023 Gabriele Gaggero, Paola Bet, Davide Taietti, Marta Ingaliso, Bruno Spina, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 13 (2022): Issue 1 (December 2022)